These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20696311)

  • 1. Recent advances in Parkinson's disease: basic research. Preface.
    Björklund A; Cenci MA
    Prog Brain Res; 2010; 183():ix-x. PubMed ID: 20696311
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent Advances in Parkinson’s disease - translational and clinical research.
    Björklund A; Cenci MA
    Prog Brain Res; 2010; 184():vii-viii. PubMed ID: 20887866
    [No Abstract]   [Full Text] [Related]  

  • 3. Basal ganglia pathophysiology in Parkinson's disease.
    Montgomery EB
    Ann Neurol; 2009 May; 65(5):618; author reply 618-9. PubMed ID: 19475660
    [No Abstract]   [Full Text] [Related]  

  • 4. Basal ganglia physiology and deep brain stimulation.
    Lozano AM; Snyder BJ; Hamani C; Hutchison WD; Dostrovsky JO
    Mov Disord; 2010; 25 Suppl 1():S71-5. PubMed ID: 20187251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of Parkinson's disease.
    Bonnet AM; Houeto JL
    Biomed Pharmacother; 1999 Apr; 53(3):117-21. PubMed ID: 10349507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hunt for a cure for Parkinson's disease.
    Andersen JK; Kumar J; Srinivas B; Kaur D; Hsu M; Rajagopalan S
    Sci Aging Knowledge Environ; 2001 Oct; 2001(1):re1. PubMed ID: 14602952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anatomy of the basal ganglia and Parkinson's disease: a review.
    Lee TK; Chau R; Leong SK
    Singapore Med J; 1995 Feb; 36(1):74-6. PubMed ID: 7570141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional neuroanatomy of the basal ganglia in Parkinson's disease.
    Wichmann T; DeLong MR
    Adv Neurol; 2003; 91():9-18. PubMed ID: 12442660
    [No Abstract]   [Full Text] [Related]  

  • 9. Understanding the dopaminergic deficits in Parkinson's disease: insights into disease heterogeneity.
    Lewis SJ; Barker RA
    J Clin Neurosci; 2009 May; 16(5):620-5. PubMed ID: 19285870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new history of basal ganglia and physiopathology of Parkinson's disease].
    Reinoso Suárez F
    An R Acad Nac Med (Madr); 2001; 118(4):771-88; discussion 788-92. PubMed ID: 12056254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy in Parkinson's disease.
    Eberhardt O; Schulz JB
    Cell Tissue Res; 2004 Oct; 318(1):243-60. PubMed ID: 15322915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal ganglia: functional perspectives and behavioral domains.
    Saint-Cyr JA
    Adv Neurol; 2005; 96():1-16. PubMed ID: 16383208
    [No Abstract]   [Full Text] [Related]  

  • 13. [Striato-cerebellar degeneration in a case of Parkinson's syndrome].
    Bignami A
    Acta Neurol (Napoli); 1967; 22(2):274-80. PubMed ID: 5606832
    [No Abstract]   [Full Text] [Related]  

  • 14. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease.
    Nakano I; Hirano A
    Ann Neurol; 1984 May; 15(5):415-8. PubMed ID: 6732189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunction of the basal ganglia, but not the cerebellum, impairs kinaesthesia.
    Maschke M; Gomez CM; Tuite PJ; Konczak J
    Brain; 2003 Oct; 126(Pt 10):2312-22. PubMed ID: 12821507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments of brain imaging for Parkinson's disease and related disorders.
    Piccini P; Brooks DJ
    Mov Disord; 2006 Dec; 21(12):2035-41. PubMed ID: 16874751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.
    Liu B; Dluzen DE
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa delivery systems for the treatment of Parkinson's disease: an overview.
    Goole J; Amighi K
    Int J Pharm; 2009 Oct; 380(1-2):1-15. PubMed ID: 19651197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming Parkinson's disease research.
    Knight AL; Daigle JG
    Dis Model Mech; 2010; 3(9-10):509-10. PubMed ID: 20647414
    [No Abstract]   [Full Text] [Related]  

  • 20. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.
    Hardman CD; Halliday GM
    Exp Neurol; 1999 Jul; 158(1):135-42. PubMed ID: 10448425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.